Clinical significance of cutaneous adverse reaction to mogamulizumab in relapsed or refractory adult T-cell leukaemia-lymphoma

被引：19

作者：

Tokunaga, Masahito ^{[1
]}

Yonekura, Kentaro ^{[2
]}

Nakamura, Daisuke ^{[3
]}

Haraguchi, Kouichi ^{[4
]}

Tabuchi, Tomohisa ^{[5
]}

Fujino, Satoshi ^{[5
]}

Hayashida, Maiko ^{[5
]}

Maekawa, Kenichi ^{[5
]}

Arai, Akihiko ^{[4
]}

Nakano, Nobuaki ^{[1
]}

Kamada, Yuhei ^{[5
]}

Kubota, Ayumu ^{[1
]}

Inoue, Hirosaka ^{[5
]}

Owatari, Satsuki ^{[4
]}

Takeuchi, Shogo ^{[1
]}

Takatsuka, Yoshifusa ^{[1
]}

Otsuka, Maki ^{[4
]}

Hanada, Shuichi ^{[4
]}

Matsumoto, Tadashi ^{[3
]}

Yoshimitsu, Makoto ^{[5
,6
]}

Ishitsuka, Kenji ^{[5
,6
]}

Utsunomiya, Atae ^{[1
]}

机构：

[1] Imamura Bun In Hosp, Dept Haematol, Kagoshima, Japan

[2] Imamura Bun In Hosp, Dept Dermatol, Kagoshima, Japan

[3] Imamura Hosp, Dept Haematol, Kagoshima, Japan

[4] Natl Hosp Org Kagoshima Med Ctr, Dept Haematol, Kagoshima, Japan

[5] Kagoshima Univ Hosp, Dept Haematol & Immunol, Kagoshima, Japan

[6] Kagoshima Univ, Div Haematol & Immunol, Ctr Chron Viral Dis, Grad Sch Med & Dent Sci, Kagoshima, Japan

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 181卷 / 04期

关键词：

adult T-cell leukaemia-lymphoma; CC chemokine receptor 4; mogamulizumab; cutaneous adverse reaction; prognostic factor;

D O I：

10.1111/bjh.14634

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：539 / 542

页数：4

共 50 条

[21] Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study
Ishida, Takashi
Jo, Tatsuro
Takemoto, Shigeki
Suzushima, Hitoshi
Uozumi, Kimiharu
Yamamoto, Kazuhito
Uike, Naokuni
Saburi, Yoshio
Nosaka, Kisato
Utsunomiya, Atae
Tobinai, Kensei
Fujiwara, Hiroshi
Ishitsuka, Kenji
Yoshida, Shinichiro
Taira, Naoya
Moriuchi, Yukiyoshi
Imada, Kazunori
Miyamoto, Toshihiro
Akinaga, Shiro
Tomonaga, Masao
Ueda, Ryuzo
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (05) : 672 - 682
[22] Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma
Zinzani, Pier Luigi
Salles, Gilles
Moskowitz, Alison J.
Santoro, Armando
Mehta, Amitkumar
Barr, Paul M.
Mehta-Shah, Neha
Collins, Graham P.
Ansell, Stephen M.
Brody, Joshua D.
Domingo-Domenech, Eva
Johnson, Nathalie A.
Cunningham, David
Ferrari, Silvia
Lisano, Julie
Krajewski, Jennifer
Wen, Rachael
Akyol, Alev
Crowe, Russell
Savage, Kerry J.
BLOOD ADVANCES, 2024, 8 (10) : 2400 - 2404
[23] Mogamulizumab for the treatment of cutaneous T-cell lymphoma: recent advances and clinical potential
Duvic, Madeleine
Evans, Mark
Wang, Casey
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2016, 7 (03) : 171 - 174
[24] Mogamulizumab for the Treatment of Adult T-cell Leukemia/Lymphoma
Ureshino, Hiroshi
Kamachi, Kazuharu
Kimura, Shinya
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (06): : 326 - 331
[25] Molecular remissions are observed in chronic adult T-cell leukaemia/lymphoma in patients treated with mogamulizumab
Cook, L.
Demontis, M. A.
Sagawe, S.
Witkover, A.
Melamed, A.
Turpin, J.
Haddow, J.
Wolf, S.
Marks, S.
Bangham, C.
Fields, P.
Taylor, G.
Rowan, A.
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 172 - 173
[26] Isolated cutaneous lymphomatous form of adult T-cell leukaemia/lymphoma
Bataller, Alex
Combalia, Andrea
Garcia-Herrera, Adriana
Estrach, Teresa
Matutes, Estella
BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (02) : 205 - 205
[27] Spontaneous regression of cutaneous lesions in adult T-cell leukaemia/lymphoma
Kawabata, H
Setoyama, M
Fukushige, T
Kanzaki, T
BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (02) : 434 - 435
[28] Clinicopathological features of cutaneous lesions of adult T-cell leukaemia/lymphoma
Yamaguchi, T
Ohshima, K
Karube, K
Tutiya, T
Kawano, R
Suefuji, H
Shimizu, A
Nakayama, J
Suzumiya, J
Moroi, Y
Urabe, K
Furue, M
Koga, T
Kikuchi, M
BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (01) : 76 - 81
[29] MOGAMULIZUMAB FOR THE TREATMENT OF ADULT T-CELL LEUKEMIA/LYMPHOMA
de Lartigue, J.
DRUGS OF TODAY, 2012, 48 (10) : 655 - 660
[30] Mogamulizumab versus investigator choice in relapsed/refractory adult T-cell leukemia/lymphoma: all four one or none for all?
Johnson, William
Mishra, Anjali
Binder, Adam
Gru, Alejandro
Porcu, Pierluigi
HAEMATOLOGICA, 2019, 104 (05) : 864 - 867

← 1 2 3 4 5 →